{"id":846,"date":"2020-02-26T14:32:16","date_gmt":"2020-02-26T19:32:16","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/preventive-med\/?page_id=846"},"modified":"2020-02-26T14:32:16","modified_gmt":"2020-02-26T19:32:16","slug":"faq","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/preventive-med\/education\/r38-primer\/faq\/","title":{"rendered":"FAQ"},"content":{"rendered":"
    \n
  1. Is there a requirement for a specific type of research in the R38 program (e.g. clinical research, population-based, basic science, etc.)?
    \nThere is no specific requirement for the type of research in the R38 program. This program offers residents to choose from four tracks based on their research interests, offering curated curricula and specialized research exposure. The four tracks for the program are, 1) Clinical cardiovascular epidemiology and translational research, 2) Genomics, computational biology and bioinformatics, 3) Health systems research and implementation science, 4) Regenerative medicine. All tracks offer opportunities for cross-track exposure and collaboration and have multidisciplinary approach.\u00a0\u00a0

    <\/span><\/em><\/li>\n
  2. Does the K38 application during fellowship need to be an extension of the research as performed under the R38 program?
    \nThe goal would be for whoever joins this program to apply to a clinical fellowship with a K38 award after residency. The K38 award would allow you to be on the path towards a strong research career. You would be able to do different research in any subspecialty if awarded the K38 after residency.<\/em>


    <\/span><\/li>\n
  3. How will the monetary compensation be arranged under the R38 program and the residency chief year? Is the resident officially graduated from the program after the third year or will the resident be switching to a “four-year” residency with an extra year of research built-in? R38 4th year will continue to be apart of the residency program. While 80% of resident\u2019s time starting the third month of PGY3 is for research purposes, the residency does not end till the end of PGY4 to allow for ABIM board eligibility (given shortened clinical training time). The compensation for PGY4 will be as per the level set by BMC GME. While technically your residency won\u2019t be done till the end of PGY4, the research chief part of the job will be woven into the PGY4 year.

    <\/span><\/li>\n
  4. How is the monetary support for any sample storage \/ bench work that the applicant might be interested in? The monetary support for sample storage etc. must come from the mentor as there is no specific R38 funding for this. There is part for meeting attendance and other logistical research related training expenditure but not for sample and research supplies itself.

    <\/span><\/em><\/li>\n
  5. What is the process of choosing a mentor?\u00a0 You could have 1 or multiple mentors depending on your interest. We will provide you with a list of mentors to choose from or choose one for you based on your research interest.<\/span>

    <\/em><\/li>\n
  6. Are participating resident-investigators eligible to perform research activities at any point during their residency even if it requires additional years of residency training?Resident-investigator participation in research activities as a part of the R38 program can occur at any point during residency training provided that each research period is a minimum of 3 consecutive months of at least 80% effort within one year of residency, and all research periods add up to a minimum of 12 months and a maximum of 24 months. Longer contiguous periods are preferred, but not required. Also, a Board recognized by the ABMS, the ADA CODA, or the ABVS must approve the overall structure of research and clinical activities outlined in the application.
    <\/span>Example scenarios of 12-month total research periods over a typical 3-year residency include but are not limited to the following:<\/span>
    <\/span>\u2022 12 months during the PGY-2 or PGY-3 year
    \u2022 Last 6 months of PGY-2 year and first 6 months of PGY-3 year
    \u2022 3 months during the PGY-2 year and 9 months during the PGY-3 year
    \u2022 3 months in PGY-1 year, 3 months in PGY-2 year, and 6 months in PGY-3 year

    <\/span><\/em><\/li>\n
  7. Will the R38 program work for short-track residents or after the completion of their residency training? Resident-investigators selected for the institutional R38 program must participate and complete all research requirements during residency, and prior to any subspecialty training (fellowship). Sufficient participation requires a minimum of 3 consecutive months with at least 80% effort in one academic year, and at least 12 months total over the duration of residency training. With approval of the overseeing Board (e.g. ABIM, ABP, ABS, etc), eligibility for a certifying examination may be achieved during participation in an accredited subspecialty fellowship.

    <\/span><\/em><\/li>\n
  8. Are there restrictions on what the residents should do with the 20% effort that is beyond the 80% effort designated for research activities?During the remaining 20% effort outside of research activities, it is anticipated that resident-investigators will perform clinical duties (e.g., continuity clinic, call back-up, night float, etc.) or other administrative activities, and maintain in good standing in their residency training program. All activities should be approved by the R38 PD\/PI and residency program director.<\/span><\/em><\/li>\n<\/ol>\n

     <\/p>\n","protected":false},"excerpt":{"rendered":"

    Is there a requirement for a specific type of research in the R38 program (e.g. clinical research, population-based, basic science, etc.)? There is no specific requirement for the type of research in the R38 program. This program offers residents to choose from four tracks based on their research interests, offering curated curricula and specialized research […]<\/p>\n","protected":false},"author":15806,"featured_media":0,"parent":831,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"page-templates\/news.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/pages\/846"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/users\/15806"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/comments?post=846"}],"version-history":[{"count":7,"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/pages\/846\/revisions"}],"predecessor-version":[{"id":853,"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/pages\/846\/revisions\/853"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/pages\/831"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/preventive-med\/wp-json\/wp\/v2\/media?parent=846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}